Robert Kania

Robert Kania has a diverse work experience in the pharmaceutical industry. Robert is currently working as a Commercial Lead at Sobi - Swedish Orphan Biovitrum AB (publ) since December 2023. Prior to this, they were a Customer Engagement Manager at Roche from April 2023 to December 2023. From October 2019 to April 2023, they worked as a Brand Value & Team Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson. Before that, they held multiple roles at Actelion Pharma Polska, including Sales Director from January 2015 to October 2019, Sales Manager from March 2011 to January 2015, and Key Account Manager from May 2009 to March 2011. Robert also worked at AstraZeneca Pharma Poland as a Hospital Key Account Associate from August 2007 to May 2009 and at Proprietary Medicinal of Hospital as a Specialist Medical Representative from August 2005 to August 2007. Their earliest work experience was as a Scientific/Medical Representative at Beaufour Ipsen from January 2003 to August 2005.

Robert Kania has a Master's degree in Microbiology and Biotechnology from Nicolaus Copernicus University, which they obtained from 1997 to 2002. Robert also has an MBA in Executive Management from Kozminski University, which they completed from 2017 to 2019. In terms of additional certifications, they hold a Pharmaceutical Business Pharma Diploma from PwC Polska, obtained in 2014. Furthermore, they have completed an Associate's degree in High Performance Leadership and Business from IMD, although the specific duration is not provided. Lastly, they pursued European Management Studies at Uniwersytet Jana Kochanowskiego w Kielcach in 2007-2008 and Human Resources Management at Wyższa Szkoła Ekonomii, Prawa i Nauk Medycznych im. prof. Edwarda Lipińskiego w Kielcach from 2008 to 2010.